While rising global life expectancy is a major achievement, it leads to more people encountering neurodegenerative diseases like Alzheimer’s and Parkinson’s. Digital speech biomarkers offer a promising tool for large-scale, low-cost screening and monitoring of neurodegenerative disorders. Emerging collaborations are actively working to democratize access to speech-based diagnostics.

To read the full article, please click here.